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roinvasion (Raeber et al., 1998; Klein et al., 2001), certain
aspects of pathogenesis can only be studied in primate
models. The macaque model, for example, proved indis-
pensable in the study of new variant Creutzfeldt-Jakob
disease (vCJD) (Will et al., 1996). Transmission of bovine
spongiform encephalopathy (BSE) to cynomolgus
macaques provided the first experimental evidence that
BSE is transmissible to a animal model that closely re-
sembles the human situation (Lasmezas et al., 1996) and
adapts itself in primates (Lasmezas et al., 2001). The is-
sue of subclinical forms of prion diseases has been
raised in a number of studies (Frigg et al., 1999; Hill et al.,
2000; Race, 2000). Because primates offer the possibility
to acquire tissue at defined time points by performing
biopsies, these animals might serve as an important
model for studying subclinical prion pathogenesis.
The gene encoding the prion protein (Prnp) has been
studied in a number of animal species. Functional as-
pects of PrPC were clarified and important insight into
species barrier mechanisms have resulted from these
studies (Schatzl et al., 1997; Wopfner et al., 1999). With
respect to vCJD the polymorphism of human PRNP at
codon 129 seems to be of utmost importance. In all vCJD
patients, methionine/methionine homozygosity has been
found in this position, whereas in caucasian populations
the usual distribution pattern is 50% heterozygosity for
methionine/valine, 40% homozygosity for methionine/
methionine and 10% homozygosity for valine/valine
(Windl et al., 1996). It has been proposed that this poly-
morphism is only present in humans. Indeed, the only
mammal that shows an amino acid other than methionine
at this position is the Wapiti deer, the gene of which pos-
sesses leucine on both alleles (Schatzl et al., 1997).
Macaque Prnp analysis has been performed on a limited
scale in past studies. The currently accepted Prnp se-
quence has been deduced from only 2 Rhesus maca-
ques.
In order to provide a reliable assessment of mutations
and allelic variants occurring in macaque Prnp, we se-
quenced the entire open reading frame of 30 Rhesus
macaques. The PrP polypeptide is encoded by a single
exon, thus permitting PCR amplification of the entire
coding region from genomic DNA. In all animals the entire
amino acid sequence of mature PrP (residues 23 – 231)
could be deduced.
Polymorphisms in Prnp occur in all mammalian
species. In humans, some of these polymorphisms are
associated with spontaneous spongiform encephalo-
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Bovine spongiform encephalopathy has been epi-
zootic in cows for the last two decades, and most
probably causes variant Creutzfeldt-Jakob disease in
humans. A thorough understanding of prion patho-
genesis relies on suitable animal models. Modeling
the transmission of BSE to primates is a crucial pub-
lic health priority, necessary for determining the tis-
sue distribution of the agent and for devising thera-
pies. Susceptibility of humans to BSE is partly
determined by polymorphism within the gene encod-
ing the cellular prion protein, Prnp, a fact that must be
taken into account in primate studies. However, no in-
formation is available on Prnp polymorphisms in
primates. We have sequenced the Prnp open reading
frames of 30 non-consanguineous Rhesus maca-
ques. All macaques were homozygous for methionine
at codon 129, which is polymorphic in humans and
seems to modulate prion susceptibility. However, we
identified a novel polymorphism in macaque Prnp, lo-
calized on codon 226 (Y226F). A modulatory effect of
this polymorphism on the development of prion dis-
ease is possible because codon 226 is close to the
suggested binding side of the factor X, which has
been invoked as a determinant of the prion species
barrier.
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Prion diseases are transmissible fatal neurodegenerative
diseases. The infectious agent is associated with an ab-
normal isoform of a cellular protein, PrPSc (Prusiner,
1991). The cellular isoform of the prion protein, PrPC, is a
glycosyl-phosphatidyl-inositol-anchored protein of un-
known physiological function. Although transgenic mice
have been used extensively for the study of prion neu-
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pathies (Hsiao et al., 1991; Aguzzi and Weissmann, 1996;
Furukawa et al., 1996). One polymorphism that seems to
be of utmost importance is the polymorphism at codon
129. In humans this codon is polymorphic, displaying
methionine/methionine, valine/valine or methionine/va-
line (Windl et al., 1996), and seems to influence the sus-
ceptibility towards the development of sporadic (Palmer
et al., 1991), iatrogenic (Collinge et al., 1991), and new
variant Creutzfeldt-Jakob disease. We were not able to
detect any polymorphism on this codon in any of our
Rhesus macaques. All of the 30 investigated animals
were homozygous for the amino acid methionine (me-
thionine/methionine) at codon 129 (Table 1). To exclude
that this is caused by genetic drift within a restricted gene
pool, the origin of the investigated animals was ascer-
tained. The screened macaques originated from different
regions of China, Burma and Central Africa (data not
shown) excluding the possibility that the non-existence
of the polymorphism on codon 129 could be caused by
consanguinity. Previous studies on a limited number of
Rhesus macaques and other primates have suggested
that codon 129 might be polymorphic in humans but not
in animals (Schatzl et al., 1995, 1997). Our study adds fur-
ther evidence that this is the case. This is reassuring
news, since it eliminates the possibility that a polymor-
phism at this position might lead to difficulties in inter-
preting past and future prion studies employing Rhesus
macaques (Brown et al., 1984; Bons et al., 1999; Las-
mezas et al., 2001). Interestingly, codon 129 seems to be
polymorphic almost exclusively in humans: the only oth-
er species that shows an animo acid other than methion-
ine at this codon is the Wapiti deer, which encodes
leucine at both positions (Schatzl et al., 1997).
Interestingly, careful analysis revealed a novel amino
acid polymorphism within the macaque Prnp gene. This
polymorphism was found on codon 226. In the published
macaque Prnp sequences, this codon contains adenine at
position 667 and encodes tyrosine. In 22 out of 30
screened animals we detected adenine on both alleles, en-
coding tyrosine. One animal was homozygous for thymine,
resulting in an amino acid change to phenylalanine, where-
as the other 7 macaques showed adenine on one allele en-
coding tyrosine, and thymine on the other encoding
phenylalanine (Table 1; Figure 1 and 2). The calculated
gene frequencies were p(Tyr) = 0.85, and q(Phe) = 0.15.
The polymorphism in codon 226 is located at the end
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Table 1 Distribution of Polymorphisms at Codon 129 and
Codon 226 in the Prnp Gene.
Codon 129 Codon 226
Met/Met 30 Tyr/Tyr 22
Met/Val 0 Tyr/Phe 7
Val/Val 0 Phe/Phe 1
All of the tested macaques were homozygous for methionine on
codon 129, while codon 226 is clearly polymorphic. Skin biop-
sies were used for the isolation of DNA. High molecular weight
genomic DNA was extracted using standard protocols. Poly-
merase chain reactions were performed according to generally
accepted protocols (Kwok and Higuchi, 1989). Every PCR in-
cluded positive and negative controls. Standard conditions for
PCR were: 250 ng of genomic DNA, 1 µmol of each primer, 0.25
mM dNTP, 1 mM MgCl2, 1.5 units of Taq DNA polymerase (5 U/µl,
Qiagen AG, Basle, Switzerland) in a final volume of 25 µl in a
commercially available PCR buffer (Qiagen). To prevent evapo-
ration, samples were covered with mineral oil (Sigma). After a
first denaturation step of three minutes at 94°C, samples were
subjected to 35 cycles of amplification consisting of 20 seconds
at 94°C, 20 s at 53°C and 120 s at 72°C on a Perkin Elmer Ge-
neAmp 9700.
The following primers were used to amplify the complete open
reading frame of the prion protein: HM-1 (TGGCGAACCTTG-
GCTGCTG), KH-13 (CCTCATCCCACTATCAGGAAG). The PCR
product was sequenced with the following primers: HM-1, 
KH-13, CH-7 (TCAGTGGCACAAGCCCAGTA) and CH-8
(GTACTCGTCCGGGGAGTATG). PCR products were separated
on a 1.5% agarose gel. PCR fragments were gel-purified (QIAEX
II Gel Extraction Kit, Qiagen). Both strands of the isolated DNA
were sequenced using the automated ABI 377 sequencing sys-
tem (Perkin Elmer). Analysis and alignment of the sequences
was performed using the ABI Prism software and ClustalW
alignment software (www2.ebi.ac.uk/clustalw).
Fig. 1 Y226F Polymorphism.
Adenine on both alleles in position 667 codes for the amino acid
tyrosine (Y) (upper panel) while adenine on one allele and thymi-
dine on the other (middle panel) and thymine on both alleles
leads to an amino acid change to phenylalanine (F) (lower panel).
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of the third α-helix, in the immediate vicinity of the gly-
cophoshatidyl inositol anchor. Whether this newly dis-
covered polymorphism has relevance to the develop-
ment of prion diseases remains to be investigated. A
retrospective study focusing on this polymorphism in
macaques that have been used in prion studies could
yield interesting insights.
Recent studies on the structure of human and bovine
PrP using NMR structure analysis have given valuable in-
formation on the three-dimensional structure and struc-
ture-functional relationships of the prion protein. As no
3D structure of macaque PrP (mcPrP) is currently avail-
able, we asked what influence a Tyr to Phe substitution at
position 226 might have on the 3D structure of human
prion protein (hPrP) (Zahn et al., 2000), and the conver-
sion of PrPC to PrPSc. Within the globular domain, there
are six amino acid substitutions between hPrP and
mcPrP (Figure 2a), corresponding to an amino acid con-
servation of 95%. All substitutions are located at the sur-
face of the molecule. This suggests that the 3D structures
of human and macaque PrP are very similar. In hPrP, the
side chain of Y226 is located at the very end of helix α3.
Approximately 60% of this residues surface is solvent-
accessible, and the closest non-sequential neighboring
residue is more that 5 Å away. Thus, it is unlikely that the
replacement of a tyrosine to a phenylalanine at position
226, which represents only a minor chemical modifica-
tion, directly influences the 3D structure of PrP. However,
it is noteworthy that this region of PrP is close to the sug-
gested binding side of the proteinaceous factor X (Telling
et al., 1995), whose existence has been invoked on the
basis of genetic evidence, and which may mediate cer-
tain aspects of the species barrier of prion diseases. Thus
a modulatory effect of this polymorphism on the develop-
ment of prion disease is certainly possible, particularly
when attempting interspecies transmission of prions.
Interestingly, in the Doppel protein (Dpl), which is the
only known protein homologous to PrP, there are similar
sequence motives in the C-terminal peptide segment:
QAYYQ in hPrP (residues 223 – 227) and EFWLE in hDpl
(residues 146 – 150). These peptide segments are mostly
conserved in the PrP and in Dpl genes studied thus far. In-
triguingly, the two aromatic residues (F147 and W148, in
Dpl; Y225 and Y226 in PrP) are (i) located at the surface of
the molecules and (ii) are evolutionary invariant. These two
facts suggest that they serve a specific function. In the 3D
structure of human Dpl (hDpl) (Mo et al., 2001), this peptide
segment, unlike in hPrP, forms a non-regular secondary
structure that folds back onto the loop connecting α2 and
β2. This structural dissimilarity is shown in Figure 2, panels
b and c. It is conceivable that under certain circumstances
a similar conformation might exist in PrP. In this case a Tyr
to Phe substitution might have a direct influence on the
stability of such a hypothetical state of PrP, and therefore
might also influence the formation of PrPSc.
We searched for further allelic variants occurring in this
Polymorphism in Primate Prnp 1023
Fig. 2 Three-Dimensional Structure of PrP.
(a) Human PrP fragment 121 – 230 (hPrP). The protein backbone is shown in grey. Regular secondary structure elements are indicated
as ribbons (α-helices) and arrows (β-strands). Amino acid side chains corresponding to species variations between humans and
macaques are shown in cyan, and the side chain corresponding to the novel polymorphism in macaques is shown in green. The amino
acid types are indicated, and the amino terminus and the carboxy terminus are indicated by ‘N’ and ‘C’, respectively. (b) Close-up of the
molecular region corresponding to the loop of PrP connecting strand β2, and helix α2, and the carboxy-terminal end of helix α3. (c)
Close-up of the molecular region of human Doppel (hDpl) corresponding to the molecular region of hPrP shown in (b). (b and c) The pro-
tein backbone is indicated by a spline function through the Cα-position of the corresponding amino acids. Disulfide bonds are shown in
yellow, and corresponding amino acid side chains between hPrP and hDpl are shown in cyan. The identities of the amino acids are in-
dicated by letters and numbers. The analysis of the 3D structure of human PrP (Protein databank code: AAD46098) was accomplished
using the program MOLMOL (Koradi et al., 1996).
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population of macaques, and were able to identify a total
of 7 allelic variants, all of them silent. A total of four Rhe-
sus macaques showed allelic variants. Animal R12 and
animal R31 both carried two common allelic variations in
nucleotide 222 and 225. In nucleotide 222 adenosine is
changed to a guanine and in nucleotide 225 guanine is
changed to adenine. Rhesus macaque R13 showed one
additional allelic variation in nucleotide 228: here we
could detect a transition of thymine to cytidine. In
macaque R27 a cytidine was substituted with a thymine
at nucleotide position 748. Rhesus macaque R30
showed three allelic variations, one at nucleotide position
189: here thymine was exchanged for cytidine. Another
allelic variation was detected in nucleotide position 261
leading to a change of thymidine to cytidine. Finally, at
nucleotide position 270 thymidine was changed to
adenosine. Allelic variations found in animal R13 were
homozygous, whereas allelic variations in other animals
were heterozygous.
Although the functional relevance of silent allelic vari-
ants in Prnp has not been determined yet (Hunter et al.,
1994), the identification of 6 new allelic variants in 4 Rhe-
sus macaques is remarkable, and may be useful in the
establishment of genetic risk profiles for the development
of prion diseases. Although none of these variants result-
ed in amino acid changes within PrP, subtle effects on
transcription and/or efficiency of translation cannot be
excluded. The clustering of these changes in only 4 out of
30 animals prompted us to study the pedigrees of the
macaques, yet this analysis did not show first-degree
kinship between animals of interest.
The Prnp gene residues 60 – 91 contain an unusual
glycine-rich repeat of eight residues (PHGGGWGQ). This
sequence is termed octarepeat region. Addition of two,
four, five, six, seven, eight or nine octarepeats in humans
results in inherited prion disease (Goldfarb et al., 1991;
Owen et al., 1992). Deletion of one octareapeat seems to
be a protective factor in goats infected with caprine pri-
ons (Goldmann et al., 1998). On the other hand, it was
shown that lemurs, which carry the shortest octarepeat
region known to date (consisting of only two octare-
peats), are highly susceptible to BSE prions (Gilch et al.,
2000). Rhesus macaques were shown to have 5 octare-
peats (Schatzl et al., 1997). We could confirm the pres-
ence of 5 octarepeats in 29 out of the 30 studied
macaques. In one macaque we could detect a deletion of
one octarepeat in one allele. The effect of this deletion
upon the susceptibility to prions remains to be elucidat-
ed.
This study answers important questions regarding the
genetic heterogeneity of the macaque Prnp gene. It con-
firms the hypothesis that codon 129 is not polymorphic in
this species. The data presented here have enabled us to
formulate a macaque Prnp consensus sequence which is
based on a sufficient number of individuals. On the other
hand, the discovery of a novel polymorphism in macaque
Prnp (Y226F) poses new questions, and the investigation
of the relevance of this polymorphism in the pathogene-
sis of prion diseases might help to resolve issues like vari-
ations of prion susceptibility in primates. Furthermore,
these results force a cautionary note on the interpretation
of previous primate studies of prion pathogenesis. It is
possible that the polymorphism identified in the current
study may influence susceptibility to BSE, sCJD and
vCJD prions. Therefore, the experimental design of such
studies will need to consider these genetic variants and
ensure that their impact be duly weighted on the results
of such studies.
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